Tejas Networks bags new order; stock locks in at upper circuit
Tejas Networks bags new order; stock locks in at upper circuit

Tejas Networks bags new order; stock locks in at upper circuit

Geyatee Deshpande Article rating: 4.1

Tejas Networks announced that it has received a new order worth Rs 32 crore from Sterlite Technologies (STL) and L&T Construction for its gigabit passive optical network (GPON) fibre-to-the-home (FTTH) equipment. Reacting to the news, the stock of the company locked in at its upper circuit of 5 per cent at Rs 64.80.

Understanding EPS
Understanding EPS

Understanding EPS

Earning Per Share

Prashant Mhaiskar Article rating: 3.0

EPS stands for earnings per share. It reduces a company’s profits on a per share basis thereby, indicating the profitability of a company. EPS is an important parameter in determining or valuing a company’s share price. It is also used to calculate the price-to-earnings ratio.

Vodafone Idea to launch a single brand ‘Vi
Vodafone Idea to launch a single brand ‘Vi

Vodafone Idea to launch a single brand ‘Vi

Rishikesh Gaikwad Article rating: 4.1

Vodafone Idea Limited informed on Monday that after almost two years of merging as a single entity, it will now also have a single brand name. The company has announced the new brand to be called ‘Vi’ (read as ‘we’). The company believes that this integration of two brands is the largest telecom integration in the world.

VA Tech Wabag wins order worth Rs 360 crore in Kingdom of Saudi Arabia
VA Tech Wabag wins order worth Rs 360 crore in Kingdom of Saudi Arabia

VA Tech Wabag wins order worth Rs 360 crore in Kingdom of Saudi Arabia

Apurva Joshi Article rating: 4.0

VA Tech Wabag Limited has secured an order to execute 300 million litres per day (MLD) Jeddah Airport 2 independent sewage treatment plant (ISTP) project at Jeddah, Kingdom of Saudi Arabia worth USD 48 million i.e. approximately Rs 360 crore.

Trending stock: Medicamen Biotech surge by 4 per cent
Trending stock: Medicamen Biotech surge by 4 per cent

Trending stock: Medicamen Biotech surge by 4 per cent

Anthony Fernandes Article rating: 4.7

The shares of Medicamen Biotech Limited (MBL) were rallying up by 4 per cent during the early trade on Monday after the company announced that it has planned to conduct its annual general meeting on September 25, 2020, wherein, the board has proposed a dividend of Re 0.5, which is 5 per cent per equity share of Rs 10. The dividend will be paid to those shareholders, whose name appears in the ‘register of members’ as on September 18, 2020.

Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection
Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection

Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection

Rishikesh Gaikwad Article rating: 5.0

Alembic Pharmaceuticals Limited announced on Monday that its wholly-owned subsidiary, Alembic Global Holding SA has received tentative approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Treprostinil Injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.3

The market opened flat on September 7, 2020, overall volumes in futures & options currently stand at 1,86,38,002 crore contracts with a turnover of Rs. 13,27,309.60 crore.

RSS
First21212122212321242126212821292130Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR